Brief: Nevro Announces FDA Approval Of Costa Rica Manufacturing Operations

Nevro

04/10/2022 21:08

Oct 4 (Reuters) - Nevro Corp  NVRO.N :
    * NEVRO ANNOUNCES FDA APPROVAL OF COSTA RICA MANUFACTURING
OPERATIONS
    * NEVRO CORP - BEGINNING IN H2 2023 CO EXPECTS TO SEE GROSS
MARGIN
EXPANSION, INCREASING OVER SUBSEQUENT THREE TO FIVE YEARS FROM
HIGH 60S% TO MID-70S%
    * NEVRO CORP - ANTICIPATES TO BEGIN SHIPPING SPINAL CORD
STIMULATION SYSTEMS BY END OF OCTOBER
    * NEVRO CORP - ANTICIPATES GRADUAL RAMP-UP OF PRODUCTION OF
SPINAL
CORD STIMULATION SYSTEMS FOR BALANCE OF YEAR AND THROUGHOUT 2023

Source text for Eikon:  ID:nPnbNpkJ4a 
Further company coverage:  NVRO.N 
 ((Reuters.Briefs@thomsonreuters.com;))